BIOPHTA is a startup based in France, most recent round Seed, 1 tracked investor.
BIOPHTA is a company headquartered in France. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
BIOPHTA is a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, specifically targeting glaucoma and macular edema, the two leading causes of blindness worldwide.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.